Nova Mentis Life Science Corp. (NMLSF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 CAD | 54.14% |
| 2022 | -0.02 CAD | 25.21% |
| 2021 | -0.02 CAD | 94.62% |
| 2020 | -0.45 CAD | -112400.0% |
| 2019 | -0.00 CAD | 99.67% |
| 2018 | -0.12 CAD | -43.37% |
| 2017 | -0.08 CAD | 44.2% |
| 2016 | -0.15 CAD | -93.8% |
| 2015 | -0.08 CAD | 79.63% |
| 2014 | -0.38 CAD | -426.32% |
| 2013 | -0.07 CAD | 96.7% |
| 2012 | -2.19 CAD | -44.08% |
| 2011 | -1.52 CAD | 48.47% |
| 2010 | -2.95 CAD | 23.38% |
| 2009 | -3.85 CAD | -93.47% |
| 2008 | -1.99 CAD | 16.74% |
| 2007 | -2.39 CAD | -168.54% |
| 2006 | -0.89 CAD | -71.15% |
| 2005 | -0.52 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.00 CAD | 28.57% |
| 2024 Q2 | -0.00 CAD | 40.0% |
| 2023 Q4 | -0.00 CAD | -7.69% |
| 2023 Q3 | -0.00 CAD | 38.1% |
| 2023 FY | - CAD | 54.14% |
| 2023 Q1 | -0.00 CAD | 51.35% |
| 2023 Q2 | -0.00 CAD | 41.67% |
| 2022 Q2 | -0.00 CAD | 50.94% |
| 2022 FY | - CAD | 25.21% |
| 2022 Q4 | -0.01 CAD | -164.29% |
| 2022 Q3 | -0.00 CAD | -7.69% |
| 2022 Q1 | -0.01 CAD | -140.91% |
| 2021 Q2 | -0.00 CAD | 32.14% |
| 2021 Q1 | -0.01 CAD | 97.33% |
| 2021 Q4 | -0.00 CAD | 82.54% |
| 2021 FY | - CAD | 94.62% |
| 2021 Q3 | -0.01 CAD | -231.58% |
| 2020 Q1 | -0.01 CAD | 26.92% |
| 2020 Q4 | -0.21 CAD | -2207.69% |
| 2020 Q2 | -0.19 CAD | -3233.33% |
| 2020 Q3 | -0.01 CAD | 95.21% |
| 2020 FY | - CAD | -112400.0% |
| 2019 Q3 | -0.01 CAD | 27.7% |
| 2019 Q4 | -0.01 CAD | 27.1% |
| 2019 Q2 | -0.01 CAD | -40.95% |
| 2019 FY | - CAD | 99.67% |
| 2019 Q1 | -0.01 CAD | 41.01% |
| 2018 Q3 | -0.03 CAD | -283.58% |
| 2018 FY | - CAD | -43.37% |
| 2018 Q4 | -0.02 CAD | 30.74% |
| 2018 Q1 | -0.08 CAD | -133.84% |
| 2018 Q2 | -0.01 CAD | 91.26% |
| 2017 FY | - CAD | 44.2% |
| 2017 Q4 | -0.03 CAD | -55.45% |
| 2017 Q3 | -0.02 CAD | -33.54% |
| 2017 Q2 | -0.02 CAD | -23.44% |
| 2017 Q1 | -0.01 CAD | 85.86% |
| 2016 Q4 | -0.09 CAD | -499.34% |
| 2016 Q3 | -0.02 CAD | 6.21% |
| 2016 Q2 | -0.02 CAD | -123.61% |
| 2016 Q1 | -0.01 CAD | 66.36% |
| 2016 FY | - CAD | -93.8% |
| 2015 Q2 | -0.01 CAD | 33.64% |
| 2015 FY | - CAD | 79.63% |
| 2015 Q4 | -0.02 CAD | -1.9% |
| 2015 Q1 | -0.02 CAD | 91.32% |
| 2015 Q3 | -0.02 CAD | -45.83% |
| 2014 Q1 | -0.02 CAD | 31.33% |
| 2014 Q2 | -0.03 CAD | -71.25% |
| 2014 FY | - CAD | -426.32% |
| 2014 Q4 | -0.25 CAD | -946.03% |
| 2014 Q3 | -0.02 CAD | 12.77% |
| 2013 Q4 | -0.02 CAD | 6.05% |
| 2013 Q3 | -0.02 CAD | -259.42% |
| 2013 Q2 | -0.01 CAD | 60.8% |
| 2013 Q1 | -0.02 CAD | 0.0% |
| 2013 FY | - CAD | 96.7% |
| 2012 FY | - CAD | -44.08% |
| 2012 Q4 | - CAD | 100.0% |
| 2012 Q3 | -0.07 CAD | -77.81% |
| 2012 Q2 | -0.04 CAD | 30.99% |
| 2012 Q1 | -0.06 CAD | 0.0% |
| 2011 Q2 | -0.28 CAD | -12.0% |
| 2011 FY | - CAD | 48.47% |
| 2011 Q3 | -0.11 CAD | 60.71% |
| 2011 Q1 | -0.25 CAD | 0.0% |
| 2011 Q4 | - CAD | 100.0% |
| 2010 FY | - CAD | 23.38% |
| 2010 Q3 | -0.37 CAD | -76.19% |
| 2010 Q2 | -0.21 CAD | 92.68% |
| 2010 Q4 | - CAD | 100.0% |
| 2010 Q1 | -2.87 CAD | 0.0% |
| 2009 Q4 | - CAD | 100.0% |
| 2009 Q1 | -1.80 CAD | 0.0% |
| 2009 FY | - CAD | -93.47% |
| 2009 Q2 | -0.97 CAD | 46.11% |
| 2009 Q3 | -0.90 CAD | 7.22% |
| 2008 Q3 | -1.12 CAD | -36.59% |
| 2008 FY | - CAD | 16.74% |
| 2008 Q1 | -0.22 CAD | 0.0% |
| 2008 Q4 | - CAD | 100.0% |
| 2008 Q2 | -0.82 CAD | -272.73% |
| 2007 Q2 | -0.46 CAD | 55.34% |
| 2007 Q3 | -0.47 CAD | -2.17% |
| 2007 Q4 | - CAD | 100.0% |
| 2007 FY | - CAD | -168.54% |
| 2007 Q1 | -1.03 CAD | 0.0% |
| 2006 FY | - CAD | -71.15% |
| 2006 Q4 | - CAD | 100.0% |
| 2006 Q3 | -0.14 CAD | -7.69% |
| 2006 Q2 | -0.13 CAD | 0.0% |
| 2006 Q1 | -0.13 CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |